IceCure Medical Stock Forecast

ICCM's stock price has decreased by -96.3% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, IceCure Medical stock has a consensus rating of "Strong Buy" and an average price target of $22.67. The average 1-year stock price forecast is 1,960.91% higher than the current stock price, while the lowest is $10 (+809.09%) and the highest is $30 (+2,627.27%).

Price Target: $22.67 (+1,960.91%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$10	$22.67	$28	$30
Change	+809.09%	+1960.9%	+2445.5%	+2627.3%

* Price targets were last updated on Aug 14, 2026.

Analyst Ratings

The average analyst rating for IceCure Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	May '26	Jun '26	Aug '26	Oct '26
Strong Buy	1	1	2	2	2	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Buy Maintains $30 → $10	Buy	Maintains	$30 → $10	+809.09%	Aug 14, 2026
Kemp Dolliver Brookline Capital Markets	Brookline Capital Markets	Buy Maintains $74	Buy	Maintains	$74	+6,581.82%	Jun 17, 2026
Scott Henry Alliance Global Partners	Alliance Global Partners	Buy Maintains $30	Buy	Maintains	$30	+2,627.27%	May 13, 2026

Financial Forecast

Revenue This Year

4.30M

from 3.38M

27.11%

from 3.38M

Revenue Next Year

8.80M

from 4.30M

104.97%

from 4.30M

EPS This Year

-4.61

from -7.20

EPS Next Year

-3.31

from -4.61

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.14M	3.09M	3.23M	3.29M	3.38M	4.30M
Revenue Growth	6.98%	-25.45%	4.67%	1.92%	2.67%	27.11%
Gross Profit	2.20M	1.45M	1.30M	1.45M	1.23M	1.67M
Gross Margin	53.04%	46.84%	40.26%	44.09%	36.28%	38.97%
Operating Income	-9.72M	-16.74M	-15.58M	-15.70M	-15.09M	-17.67M
Net Income	-9.90M	-16.98M	-14.65M	-15.32M	-15.06M	-17.66M
EPS	-	-	-	-	-7.20	-4.61
Free Cash Flow	-	-	-	-	-14.61M	-11.45M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	4.4M
Avg	4.3M
Low	4.2M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	29.3%
Avg	27.1%
Low	24.9%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-4.61
Avg	-4.61
Low	-4.61

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-